AbbVie Reports Third-Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Tech selloff weighs down Wall Street as bond yields climb
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
AbbVie (ABBV) Tops Q3 EPS by 3c, Updates FY Guidance
November 1, 2019 7:50 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $2.33, $0.03 better than the analyst estimate of $2.30. Revenue for the quarter came in at $8.48 billion versus the consensus estimate of $8.38 billion.
GUIDANCE:
AbbVie sees FY2019 EPS of $8.90-$8.92, versus the consensus of... More
